Zydus Cadila has received the approval for Emergency Use Authorization (EUA) from the Drug Controller General of India (DCGI) for which vaccine, in August 2021 ?

Correct option is A

Sol: The correct answer is (a) ZyCoV-D

Key Points:

In August 2021, Zydus Cadila received Emergency Use Authorization (EUA) from the Drug Controller General of India (DCGI)for ZyCoV-D, the world’s first plasmid DNA vaccine for COVID-19. It is also notable for being the first COVID-19 vaccine in India that can be administered to individuals aged12 years and above.

1. Needle-free administration: The vaccine is delivered using a painless, needle-free injector.
2. Three-dose regimen: The vaccine requires three doses administered on day 0, day 28, and day 56.
3. Innovative technology: It is based on a plasmid DNA platform, which triggers an immune response to fight COVID-19.

Information booster:

​Drug Controller General of India (DCGI):

• ​The Drug Controller General of India (DCGI) is the head of the Central Drugs Standard Control Organization (CDSCO), which is the national regulatory authority for ensuring the safety, efficacy, and quality of drugs and cosmetics in India.
• The DCGI is responsible for the approval of licenses for specified categories of drugs, such as blood and blood products, IV fluids, vaccines​